| Literature DB >> 33675823 |
Erlend C S Landsend1, Neil Lagali2, Tor P Utheim3.
Abstract
Congenital aniridia is a rare genetic eye disorder with total or partial absence of the iris from birth. In most cases the genetic origin of aniridia is a mutation in the PAX6 gene, leading to involvement of most eye structures. Hypoplasia of the fovea is usually present and is associated with reduced visual acuity and nystagmus. Aniridia-associated keratopathy, glaucoma, and cataract are serious and progressive complications that can further reduce visual function. Treatment of the ocular complications of aniridia is challenging and has a high risk of side effects. New approaches such as stem cell therapy may, however, offer better prognoses. We describe the various ocular manifestations of aniridia, with a special focus on conditions that commonly require treatment. We also review the growing literature reporting systemic manifestations of the disease.Entities:
Keywords: Aniridia; Cataract; Complications; Dry eye disease; Foveal hypoplasia; Genetics; Glaucoma; Keratopathy; Systemic findings; Treatment
Mesh:
Year: 2021 PMID: 33675823 DOI: 10.1016/j.survophthal.2021.02.011
Source DB: PubMed Journal: Surv Ophthalmol ISSN: 0039-6257 Impact factor: 6.048